CA Stock MarketDetailed Quotes
ENBI Entheon Biomedical Corp
- 0.130
- 0.0000.00%
15min DelayMarket Closed Nov 7 15:55 ET
1.15MMarket Cap-3250P/E (TTM)
0.130High0.130Low26.50KVolume0.130Open0.130Pre Close3.45KTurnover0.25052wk High0.31%Turnover Ratio8.86MShares0.05052wk Low-0.04EPS TTM1.11MFloat Cap13.500Historical HighLossP/E (Static)8.57MShs Float0.050Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM5.00P/B1Lot Size--Div YieldTTM
Entheon Biomedical Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -40.13%228.6K | -38.57%299.14K | -49.09%249.92K | -49.33%344.63K | -49.33%344.63K | 53.72%381.81K | 4.14%486.93K | -40.23%490.91K | -66.81%680.17K | -66.81%680.17K |
| -Cash and cash equivalents | -40.13%228.6K | -37.49%299.14K | -49.09%249.92K | -49.33%344.63K | -49.33%344.63K | 53.72%381.81K | 2.35%478.56K | -40.23%490.91K | -66.81%680.17K | -66.81%680.17K |
| -Short term investments | ---- | ---- | ---- | ---- | ---- | --0 | --8.37K | ---- | ---- | ---- |
| Receivables | -62.62%4.06K | -43.12%4.03K | -92.23%6.45K | -85.23%6.23K | -85.23%6.23K | -75.69%10.87K | -76.30%7.08K | 255.94%83K | 49.10%42.19K | 49.10%42.19K |
| -Other receivables | -62.62%4.06K | -43.12%4.03K | -92.23%6.45K | -85.23%6.23K | -85.23%6.23K | -75.69%10.87K | -76.30%7.08K | 255.94%83K | 49.10%42.19K | 49.10%42.19K |
| Inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.93%13.81K | ---- | ---- |
| Prepaid assets | -58.64%11.66K | -50.80%27.22K | -47.80%30.53K | 106.80%45.21K | 106.80%45.21K | -89.89%28.19K | -90.71%55.32K | -93.20%58.49K | -98.02%21.86K | -98.02%21.86K |
| Total current assets | -41.95%244.32K | -39.86%330.38K | -55.60%286.9K | -46.78%396.08K | -46.78%396.08K | -28.29%420.87K | -50.46%549.32K | -62.70%646.21K | -76.80%744.22K | -76.80%744.22K |
| Non current assets | ||||||||||
| Other non current assets | -50.00%5K | -80.00%5K | -80.00%5K | -80.00%5K | -80.00%5K | --10K | --25K | --25K | --25K | --25K |
| Total non current assets | -50.00%5K | -80.00%5K | -80.00%5K | -80.00%5K | -80.00%5K | -99.84%10K | -99.60%25K | -99.62%25K | -99.63%25K | -99.63%25K |
| Total assets | -42.14%249.32K | -41.60%335.38K | -56.51%291.9K | -47.86%401.08K | -47.86%401.08K | -93.56%430.87K | -92.24%574.32K | -91.93%671.21K | -92.29%769.22K | -92.29%769.22K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -51.43%20.19K | ---- | -66.16%51.01K | -44.83%85.33K | -44.83%85.33K | -33.77%41.57K | -92.18%89.04K | -84.44%150.73K | -83.33%154.65K | -83.33%154.65K |
| -accounts payable | -51.43%20.19K | ---- | -66.16%51.01K | -44.83%85.33K | -44.83%85.33K | -33.77%41.57K | -89.38%89.04K | -84.44%150.73K | -83.33%154.65K | -83.33%154.65K |
| Current liabilities | -51.43%20.19K | -53.33%41.55K | -66.16%51.01K | -44.83%85.33K | -44.83%85.33K | -33.77%41.57K | -92.18%89.04K | -84.44%150.73K | -83.33%154.65K | -83.33%154.65K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -51.43%20.19K | -53.33%41.55K | -66.16%51.01K | -44.83%85.33K | -44.83%85.33K | -33.77%41.57K | -92.18%89.04K | -84.44%150.73K | -83.33%154.65K | -83.33%154.65K |
| Shareholders'equity | ||||||||||
| Share capital | 3.66%20.06M | 3.66%20.06M | 3.14%19.96M | 3.14%19.96M | 3.14%19.96M | 0.00%19.35M | 0.00%19.35M | 0.00%19.35M | 0.00%19.35M | 0.00%19.35M |
| -common stock | 3.66%20.06M | 3.66%20.06M | 3.14%19.96M | 3.14%19.96M | 3.14%19.96M | 0.00%19.35M | 0.00%19.35M | 0.00%19.35M | 0.00%19.35M | 0.00%19.35M |
| Retained earnings | -4.44%-21.54M | -4.60%-21.48M | -3.40%-21.38M | 1.40%-21.31M | 1.40%-21.31M | -27.13%-20.63M | -23.07%-20.53M | -34.17%-20.68M | -59.54%-21.61M | -59.54%-21.61M |
| Gains losses not affecting retained earnings | 2.81%1.71M | 2.74%1.71M | -9.91%1.66M | -42.09%1.66M | -42.09%1.66M | -52.46%1.66M | -53.70%1.66M | -45.89%1.85M | -11.42%2.87M | -11.42%2.87M |
| Total stockholders'equity | -41.14%229.13K | -39.45%293.83K | -53.72%240.89K | -48.62%315.75K | -48.62%315.75K | -94.13%389.29K | -92.25%485.29K | -92.92%520.48K | -93.21%614.57K | -93.21%614.57K |
| Total equity | -41.14%229.13K | -39.45%293.83K | -53.72%240.89K | -48.62%315.75K | -48.62%315.75K | -94.13%389.29K | -92.25%485.29K | -92.92%520.48K | -93.21%614.57K | -93.21%614.57K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data